The American Journal of Managed Care4d
FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis
The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the ...
Healio9d
Green orthopedics: Spend our precious health care dollars wisely
Orthopedic surgery is a marvelous field because we can make meaningful improvements in the comfort and function of patients ...
The American Journal of Managed Care29d
FDA Approves Generic Lenalidomide Capsules in Multiple Strengths
FDA approved Amneal's generic lenalidomide capsules, referencing Celgene's Revlimid, for manufacturing and sale starting in 2026. Amneal launched mesalamine 800 mg delayed-release tablets for ...
Healthline11d
Side Effects of Zepbound: What You Need to Know
Zepbound (tirzepatide) can cause side effects that range from mild to serious. More common side effects include nausea, diarrhea, and constipation. If side effects from Zepbound become hard to ...
Healthline29d
Dosage Details for Leqvio
The usual Leqvio (inclisiran) dosage for certain kinds of high cholesterol is 284 milligrams per 1.5 milliliters (mg/mL). Specific dosages may vary depending on factors like your individual ...
MPR1d
FDA Approves Losartan Oral Suspension Arbli
The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor ...
PharmiWeb17h
New data on investigational therapy for thymidine…
UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...
MPR1d
Baqsimi Approved for Severe Hypoglycemia Treatment in Younger Patients
The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in ...
rheumatologyadvisor9d
Denosumab Biosimilars Stoboclo, Osenvelt Get FDA Approval
The products are expected to be available in June 2025. Osenvelt is indicated to prevent skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid ...
New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference
UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...
Medical News Today3d
Imbruvica for chronic lymphocytic leukemia
Imbruvica (ibrutinib) is a brand-name drug that’s prescribed for chronic lymphocytic leukemia (CLL). This article covers topics such as side effects, dosage, and how Imbruvica works. Imbruvica ...
clinicaladvisor.com13d
FDA Approves First Generics of Anticoagulant Xarelto
The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with ...